Navigation Links
DNA-damage Test Could Aid Drug Development

In the daunting marathon that leads to successful drugs, promising drug candidates must pass toxicity tests before entering clinical trials. Researchers from Massachusetts Institute of Technology and Whitehead Institute have developed a cell culture test for assessing a compounds genetic toxicity that may prove dramatically cheaper than existing animal tests. This assay would allow genetic toxicity to be examined far earlier in the drug development process, making it much more efficient.

Like the current FDA-approved test, the new test looks for DNA damage in red blood cells formed in the bone marrow of mice. The precursors to red blood cells are handy for this because such cells normally lose their nucleus during the last stage of red cell formation, and DNA-damaged precursors generate red blood cells containing an easily detected 'micronucleus' consisting of fragments of nuclear DNA. Unlike the current procedure, which injects the compound into a live mouse, the new assay is a cell-culture system that could allow hundreds or thousands of tests to be performed from the bone marrow of a single mouse, and potentially from human bone marrow.

Joe Shuga, the graduate student in chemical engineering who developed the assay, is in the unusual position of being a graduate student in three labs, those of Professors Linda Griffith, Harvey Lodish (a Whitehead Member) and Leona Samson. 'We're all faculty in the Biological Engineering department, and collaborative projects like this are what the department was intended to do,' comments Griffith.

'This is an example of taking fundamental lab science and doing something useful with it,' says Lodish, whose lab has extensively studied the process by which red blood cells are generated. Shuga first worked with postdoctoral researcher Jing Zhang in the Lodish lab to adapt techniques from an established cell-culture system based on mouse fetal liver cells to create a new system based on adult
'"/>




Page: 1 2 3

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Nasal Spray Could Take Drugs Direct to Brain.
3. Nasal Spray Could Take Drugs Directly to Brain
4. Oxygen Usage During Exercise Could Indicate Heart Problems
5. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
6. Anger Could Be Linked To Weight Gain
7. A Seizure Late In Life Could be A Stroke Warning
8. New Findings Could Reduce The Extent Of Spinal Cord Injuries
9. Could There Be A Link Between Famine and Breast Cancer ?
10. Bone Marrow Cells Could Yield A New Lease of Life
11. New Hair in 15 Days Could Now Be A Possibility Say Researchers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DNA damage Test Could Aid Drug Development

(Date:11/23/2009)...a simple case for a New York auto accident attorne... , New York (PRWEB) Novemb...w York auto accident attorneys passed to criminal...ed fatal., , , , ,According to the New York Dail...d killed during a heated road-rage argument. Accor...
(Date:11/23/2009)...lationHealthPrograms ,, LOVELAND,Ohio,Nov.23/P...stitute(PHII),anon-profit501(c)(3)organization,isp...ovedtheHealthcareTransparencyAccreditationProgram,...M),alife,health,andwellnesscompanybasedinFarmingto...tationsealforfiveofitsprograms. ,, ThomasW.Wils...
(Date:11/23/2009)...vingweekendmarksthe36thannualStateFarmBayouClassic...esportsmanshipandprideoftwoschoolsbutitissomuchmor...ce. ,, ForthecrewofthenewU.S.CoastGuardship,the...rktotestandlaunchabrandnewshiptoprotectourshores. ...deBovellandtherestofthecrewwillbegintestingtheship...
(Date:11/23/2009)...bly captured the attention of public health offici...s from Children,s Hospital Boston, based on patien...veral recent flu seasons, shows that another virus...stantially greater disease toll among young childr...ome from the pre-H1N1 influenza era, the analysis,...
(Date:11/23/2009)...t outcomes, research suggests , , MONDAY...ug therapy shows promise in treating patients with..., The study from the Massachusetts General Hosp...nd tumor response in patients treated with bevaciz... helped slow the growth of other cancers, in addit...
Breaking Medicine News(10 mins):Health News:An Incident of Road Rage Turns Into Murder 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 3Health News:Nothing Is Like Being There 2Health News:Amid the flu epidemic, don't forget RSV in young children 2Health News:Amid the flu epidemic, don't forget RSV in young children 3Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2
...nc. (Nasdaq:,ICAD), an industry-leading provider o... early identification of cancer, today announced t... with the private equity,firm, Welsh, Carson, Ande...mber of directors to eight. Mr. Ecock, age,46, bri...
... with New President, Congress on,Public-Private Ef...h Care,Payment Systems to Emphasize Wellness, Evid... of chief,executives from many of the nation,s lea...th care gap, between the status,quo and the ,healt...
...] Scientists at the Swedish medical university Kar...n that a receptor called ALK7 plays important role... as the release of insulin from beta-cells in the ...moving the ALK7 receptor improves insulin release ...
...ess Releases its 2007 Claims Review from,Leading I...ion Data,, PORTLAND, Maine, May 13 Data from the...d today by the Council for,Disability Awareness (C...ng-term disabilities has grown four times,the grow...
...-PRNewswire-FirstCall/ -- China Sky One,Medical, I...C Bulletin,Board: CSKI), a leading fully integrate...e-counter drugs in the People,s Republic of China,...aldorf Astoria in New York City., Mr. Yanqing Liu...
... Promising results from a team of NewYork-Presbyte...an-scientists show that gene therapy is both safe ... disease, or Late Infantile Neuronal Ceroid Lipofu...rial found that the procedure -- which involves in...
Other Medicine News:Health News:iCAD, Inc. Appoints Anthony F. Ecock to Board of Directors 2Health News:CEOs From Multiple Health Industries Announce Consensus Plan to Reform U.S. Health Care 2Health News:CEOs From Multiple Health Industries Announce Consensus Plan to Reform U.S. Health Care 3Health News:Novel mechanisms controlling insulin release and fat deposition discovered 2Health News:New Data Shows Continued Growth of Long-Term Disability Claims and Decline in Social Security Disability Insurance Applications Approval Rate 2Health News:New Data Shows Continued Growth of Long-Term Disability Claims and Decline in Social Security Disability Insurance Applications Approval Rate 3Health News:China Sky One Medical, Inc. to Present at Brean Murray Carret & Co. All-Cap All-China Conference 2Health News:NYP/Weill Cornell gene therapy clinical trial yields promising results for Batten disease 2
(Date:11/23/2009)...RINCETON,N.J.,Nov.23/PRNewswire-FirstCall/--Pharma...lmentofCohort2,ledbyitspartnerRoche(SWX:ROG.VX;RO....ype1and4patientsintheongoingphase2btrialofRG7128,a...orthetreatmentofchronichepatitisCvirus(HCV)infecti...ndependentDataMonitoringCommittee(DMC)ofallavailab...
(Date:11/23/2009)...OVATO,Calif.,Nov.23/PRNewswire-FirstCall/--RaptorP... RPTP ),todayannouncedresultsfromaPhase2bclinicalt...trate("DRCysteamine")inpatientswithnephropathiccys...rsityofCalifornia,SanDiego("UCSD")GeneralClinicalR...okineticsandpharmacodynamicsofasingledoseofDRCyste...
(Date:11/23/2009)...LISOVIEJO,Calif.,Nov.23/PRNewswire-FirstCall/--Oce...als International(NYSE: VRX ),todayannouncedthatit...iniumbromide,anauthorizedgeneric(AG)versionofLibra...tstobeasignificantplayerintheLibrax®genericma...rtantdivisionofourU.S.businesswithitssuccessfullau...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2U S Faces Shortage of Heart Surgeons 56866 1U S Faces Shortage of Heart Surgeons 56866 2U S Faces Shortage of Heart Surgeons 56866 3Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox Restylane Radiesse and Others 56864 1Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox Restylane Radiesse and Others 56864 2Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox Restylane Radiesse and Others 56864 3CBS Radio Presents Cars for Courage Boat Drive Sept 13 56861 1CBS Radio Presents Cars for Courage Boat Drive Sept 13 56861 2
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: